Contact Us

PW Case Review Form
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

Phone 

Please describe your case:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Breaking Legal News

FDA Reconsidering Avandia Restrictions

Jun 3, 2013
The knell appeared to sound for Avandia a few years ago when federal health officials decided to almost ban the drug outright because it had been...

The FDA's New Rules for Sunscreens

Jun 3, 2013
This year’s quickly approaching summer season will see changes in how sunscreens are labeled, as most sunscreen on store shelves will have to...

European Health Regulatory Agency Recommends Restrictions on Epilepsy Drug Trobalt

Jun 3, 2013
On Friday, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended restricting the epilepsy...

FDA Panel to Reconsider Restrictions on Diabetes Drug Avandia

Jun 3, 2013
A panel of experts will meet this week to advise the U.S. Food and Drug Administration (FDA) in its reconsideration of restrictions placed on the...

Arkansas Man Claims Byetta Caused Pancreatic Cancer

Jun 3, 2013
An Arkansas man claims that taking the type 2 diabetes drug Byetta caused him to develop pancreatic cancer. After developing pancreatic cancer and...

Internal FDA Dispute Continues Over Popular Blood Pressure Drugs and Cancer Links

Jun 3, 2013
Some popular blood pressure medications are at the center of an internal ruckus at the U.S. Food and Drug Administration (FDA). Angiotensin receptor...

Risk of Liver Injury Seen with Samsca

May 31, 2013
Clinical trials have revealed drug-induced liver injury in patients taking Samsca (tolvaptan). Samsca was being tested for an unapproved use in...

Roche Warns of Potential Risk of Fatal Skin Reactions Linked to MabThera

May 31, 2013
Health authorities in Europe along with Roche Registration Ltd. have issued a warning about a potential risk of fatal skin reactions caused by...

Thalidomide Increases Risk of Second Primary Malignancies, UK Drug Safety Agency Warns

May 31, 2013
The (U.K.) Medicines and Healthcare Regulatory Agency (MHRA) has issued a warning of the risk of developing a second primary malignancy for patients...

Federal Officials Investigate Potential Link Between Diabetes Drug Januvia and Pancreatic Cancer

May 31, 2013
Federal health officials are set to launch an investigation into a possible link between the type 2 diabetes drug Januvia (sitagliptin) and a risk of...

Page 4/1630 [first] [prev] 1 2 3 4 5 6 7 8 9 10 ... [next] [last]

Law Dragon Best Lawyers Peer Review Rated Avvo Protected by Copyscape Web Copyright Protection Software php-5